LICENSE AND COLLABORATION AGREEMENT DATED AS OF JULY 11, 2008 BY AND BETWEEN IMMUNOMEDICS, INC. AND NYCOMED GmbHLicense and Collaboration Agreement • August 29th, 2008 • Immunomedics Inc • In vitro & in vivo diagnostic substances
Contract Type FiledAugust 29th, 2008 Company IndustryThis License and Collaboration Agreement (this “Agreement”), dated as of July 11, 2008 (the “Execution Date”), is made by and between Immunomedics, Inc., a Delaware corporation (“Immunomedics”) headquartered at 300 American Road, Morris Plains, New Jersey 07950, USA, and Nycomed GmbH, a corporation organized under the laws of Germany (“Licensee”) headquartered at Byk-Gulden-Str. 2 78467 Konstanz, Germany. Immunomedics and Licensee are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
LOAN AGREEMENT executed by and between IMMUNOMEDICS, INC., as the Borrower and BANK OF AMERICA, N.A., as the Bank Dated: June 6, 2008Loan Agreement • August 29th, 2008 • Immunomedics Inc • In vitro & in vivo diagnostic substances • New Jersey
Contract Type FiledAugust 29th, 2008 Company Industry JurisdictionTHIS LOAN AGREEMENT (hereinafter, as it may be from time to time amended, modified, extended, renewed, refinanced and/or supplemented, referred to as this “Loan Agreement”), is made this 6th day of June, 2008 (hereinafter referred to as the “Effective Date”), by and between